Palivizumab prophylaxis in patients admitted to the pediatric intensive care unit (PICU) with respiratory syncytial virus (RSV).

被引:0
|
作者
Feller, AE
Morrison, WE
Straumanis, JP
机构
[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[2] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
关键词
D O I
10.1097/00003246-200512002-00327
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:A92 / A92
页数:1
相关论文
共 50 条
  • [41] Palivizumab prophylaxis, respiratory syncytial virus and subsequent development of asthma
    Igde, M.
    Kabasakal, H.
    Ozturk, O.
    Karatekin, G.
    Aygun, C.
    ALLERGY, 2016, 71 : 534 - 534
  • [42] A 4-year survey on palivizumab respiratory syncytial virus (RSV)-prophylaxis: How can compliance be improved?
    Pignotti, MS
    Catarzi, S
    Donzelli, G
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2006, 19 (04): : 221 - 224
  • [43] A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)
    B. Paes
    I. Mitchell
    A. Li
    K. L. Lanctôt
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 2703 - 2711
  • [44] A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS)
    Paes, B.
    Mitchell, I.
    Li, A.
    Lanctot, K. L.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (10) : 2703 - 2711
  • [45] Effects of Community-wide Respiratory Syncytial Virus Immune Globulin Prophylaxis on Pediatric Intensive Care Unit Admissions † 816
    Steven C Buckingham
    Michael W Quasney
    John P DeVincenzo
    Pediatric Research, 1998, 43 (Suppl 4) : 141 - 141
  • [46] Respiratory syncytial virus outbreak in neonatal intensive care unit: Impact of infection control measures plus palivizumab use
    Silva, Camila de A.
    Dias, Livio
    Baltieri, Sandra R.
    Rodrigues, Tatiane T.
    Takagi, Neusa Brandolise
    Richtmann, Rosana
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2012, 1
  • [47] Respiratory syncytial virus is present in the neonatal intensive care unit
    Homaira, Nusrat
    Sheils, Joanne
    Stelzer-Braid, Sacha
    Lui, Kei
    Oie, Ju-Lee
    Snelling, Tom
    Jaffe, Adam
    Rawlinson, William
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (02) : 196 - 201
  • [48] Respiratory syncytial virus outbreak in neonatal intensive care unit: Impact of infection control measures plus palivizumab use
    Camila de A Silva
    Lívio Dias
    Sandra R Baltieri
    Tatiane T Rodrigues
    Neusa Brandolise Takagi
    Rosana Richtmann
    Antimicrobial Resistance and Infection Control, 1
  • [49] Prophylactic Palivizumab Prevents Respiratory Syncytial Virus Infection in Pediatric Patients with Immunodeficiencies
    Koganesawa, Masaya
    Ono, Takahiro
    Takamido, Shotaro
    Takagi, Toshiyuki
    Yamaoka, Daishiro
    Ujiie, Gakuto
    Kanazawa, Takeru
    Kaneko, Ryota
    Okamoto, Naoko
    Fuzita, Sachio
    Ogawa, Rei
    Suzuki, Manabu
    Huzimoto, Yoko
    Akiyama, Kosuke
    Matsuno, Ryosuke
    Toyama, Daisuke
    Ikeda, Hirokazu
    Yamamoto, Shohei
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S39 - S39
  • [50] Palivizumab - the humanised monoclonal antibody for prevention of respiratory syncytial virus (RSV) infection
    Scholz, H
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2000, 204 (03): : 120 - 122